title: Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion.
authors.forename: Maria J
authors.initials: MJ
authors.lastname: Peñarrubia
authors.forename: Luz A
authors.initials: LA
authors.lastname: Silvestre
authors.forename: Joaquina
authors.initials: J
authors.lastname: Conde
authors.forename: Alberto
authors.initials: A
authors.lastname: Cantalapiedra
authors.forename: Luis J
authors.initials: LJ
authors.lastname: Garcia Frade
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide